Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.

about

Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells.

P2860

Q54117757-1C9646C2-53C0-4CC9-BEB8-3EEE7CCE9C23

P2860

Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.

Item

http://www.wikidata.org/entity/Q36034972

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effects of epidermal growth fa ...... in canine osteosarcoma cells.

@ast

Effects of epidermal growth fa ...... in canine osteosarcoma cells.

@en

type

Item

label

Effects of epidermal growth fa ...... in canine osteosarcoma cells.

@ast

Effects of epidermal growth fa ...... in canine osteosarcoma cells.

@en

prefLabel

Effects of epidermal growth fa ...... in canine osteosarcoma cells.

@ast

Effects of epidermal growth fa ...... in canine osteosarcoma cells.

@en

P1476

Effects of epidermal growth fa ...... in canine osteosarcoma cells.

@en

P2093

Fernanda B Mantovani

http://www.w3.org/2001/XMLSchema#string

Jodi A Morrison

http://www.w3.org/2001/XMLSchema#string

P2860

ERBB receptors and cancer: the complexity of targeted inhibitors

Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression.

Radiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer.

A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study.

Epidermal growth factor receptor expression in canine transitional cell carcinoma

Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines.

Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer

A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck.

The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents.

P2888

s12917-016-0707-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12917-016-0707-7

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anthony J Mutsaers

P577

2016-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1026519842

http://www.w3.org/2001/XMLSchema#string

P698

27245053

http://www.w3.org/2001/XMLSchema#string

P932

4888507

http://www.w3.org/2001/XMLSchema#string

Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.

about

P2860

P2860

Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P932